ARTICLE | Distillery Therapeutics
Inhibiting RPS6KA6 with floxacin antibiotics for bladder, lung cancers
July 30, 2021 7:16 PM UTC
DISEASE CATEGORY: Cancer
INDICATION: Bladder cancer; lung cancer...
BCIQ Company Profiles
BCIQ Target Profiles
Ribosomal protein S6 kinase 90kDa polypeptide 6 (RPS6KA6) (RSK4)